Bullish option flow detected in Iovance Biotherapeutics with 2,929 calls trading, 1.1x expected, and implied vol increasing over 21 points to 218.44%. Mar-24 11 calls and Feb-24 9 puts are the most active options, with total volume in those strikes near 1,600 contracts. The Put/Call Ratio is 0.45. Earnings are expected on February 27th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IOVA:
- Iovance Biotherapeutics call volume above normal and directionally bullish
- Unusually active option classes on open January 26th
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Iovance clinical hold does not impact other trials, says JMP Securities
- Iovance expects to quickly address clinical hold, says Barclays